Cargando…

Identification of molecularly unique tumor-associated mesenchymal stromal cells in breast cancer patients

The tumor microenvironment is a complex mixture of cell types that bi-directionally interact and influence tumor initiation, progression, recurrence, and patient survival. Mesenchymal stromal cells (MSCs) of the tumor microenvironment engage in crosstalk with cancer cells to mediate epigenetic contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, Jonathan A. R., Evans, Mark F., Ghule, Prachi N., Lee, Kyra, Vacek, Pamela, Sprague, Brian L., Weaver, Donald L., Stein, Gary S., Stein, Janet L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027225/
https://www.ncbi.nlm.nih.gov/pubmed/36940196
http://dx.doi.org/10.1371/journal.pone.0282473
_version_ 1784909672287830016
author Gordon, Jonathan A. R.
Evans, Mark F.
Ghule, Prachi N.
Lee, Kyra
Vacek, Pamela
Sprague, Brian L.
Weaver, Donald L.
Stein, Gary S.
Stein, Janet L.
author_facet Gordon, Jonathan A. R.
Evans, Mark F.
Ghule, Prachi N.
Lee, Kyra
Vacek, Pamela
Sprague, Brian L.
Weaver, Donald L.
Stein, Gary S.
Stein, Janet L.
author_sort Gordon, Jonathan A. R.
collection PubMed
description The tumor microenvironment is a complex mixture of cell types that bi-directionally interact and influence tumor initiation, progression, recurrence, and patient survival. Mesenchymal stromal cells (MSCs) of the tumor microenvironment engage in crosstalk with cancer cells to mediate epigenetic control of gene expression. We identified CD90+ MSCs residing in the tumor microenvironment of patients with invasive breast cancer that exhibit a unique gene expression signature. Single-cell transcriptional analysis of these MSCs in tumor-associated stroma identified a distinct subpopulation characterized by increased expression of genes functionally related to extracellular matrix signaling. Blocking the TGFβ pathway reveals that these cells directly contribute to cancer cell proliferation. Our findings provide novel insight into communication between breast cancer cells and MSCs that are consistent with an epithelial to mesenchymal transition and acquisition of competency for compromised control of proliferation, mobility, motility, and phenotype.
format Online
Article
Text
id pubmed-10027225
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-100272252023-03-21 Identification of molecularly unique tumor-associated mesenchymal stromal cells in breast cancer patients Gordon, Jonathan A. R. Evans, Mark F. Ghule, Prachi N. Lee, Kyra Vacek, Pamela Sprague, Brian L. Weaver, Donald L. Stein, Gary S. Stein, Janet L. PLoS One Research Article The tumor microenvironment is a complex mixture of cell types that bi-directionally interact and influence tumor initiation, progression, recurrence, and patient survival. Mesenchymal stromal cells (MSCs) of the tumor microenvironment engage in crosstalk with cancer cells to mediate epigenetic control of gene expression. We identified CD90+ MSCs residing in the tumor microenvironment of patients with invasive breast cancer that exhibit a unique gene expression signature. Single-cell transcriptional analysis of these MSCs in tumor-associated stroma identified a distinct subpopulation characterized by increased expression of genes functionally related to extracellular matrix signaling. Blocking the TGFβ pathway reveals that these cells directly contribute to cancer cell proliferation. Our findings provide novel insight into communication between breast cancer cells and MSCs that are consistent with an epithelial to mesenchymal transition and acquisition of competency for compromised control of proliferation, mobility, motility, and phenotype. Public Library of Science 2023-03-20 /pmc/articles/PMC10027225/ /pubmed/36940196 http://dx.doi.org/10.1371/journal.pone.0282473 Text en © 2023 Gordon et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Gordon, Jonathan A. R.
Evans, Mark F.
Ghule, Prachi N.
Lee, Kyra
Vacek, Pamela
Sprague, Brian L.
Weaver, Donald L.
Stein, Gary S.
Stein, Janet L.
Identification of molecularly unique tumor-associated mesenchymal stromal cells in breast cancer patients
title Identification of molecularly unique tumor-associated mesenchymal stromal cells in breast cancer patients
title_full Identification of molecularly unique tumor-associated mesenchymal stromal cells in breast cancer patients
title_fullStr Identification of molecularly unique tumor-associated mesenchymal stromal cells in breast cancer patients
title_full_unstemmed Identification of molecularly unique tumor-associated mesenchymal stromal cells in breast cancer patients
title_short Identification of molecularly unique tumor-associated mesenchymal stromal cells in breast cancer patients
title_sort identification of molecularly unique tumor-associated mesenchymal stromal cells in breast cancer patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027225/
https://www.ncbi.nlm.nih.gov/pubmed/36940196
http://dx.doi.org/10.1371/journal.pone.0282473
work_keys_str_mv AT gordonjonathanar identificationofmolecularlyuniquetumorassociatedmesenchymalstromalcellsinbreastcancerpatients
AT evansmarkf identificationofmolecularlyuniquetumorassociatedmesenchymalstromalcellsinbreastcancerpatients
AT ghuleprachin identificationofmolecularlyuniquetumorassociatedmesenchymalstromalcellsinbreastcancerpatients
AT leekyra identificationofmolecularlyuniquetumorassociatedmesenchymalstromalcellsinbreastcancerpatients
AT vacekpamela identificationofmolecularlyuniquetumorassociatedmesenchymalstromalcellsinbreastcancerpatients
AT spraguebrianl identificationofmolecularlyuniquetumorassociatedmesenchymalstromalcellsinbreastcancerpatients
AT weaverdonaldl identificationofmolecularlyuniquetumorassociatedmesenchymalstromalcellsinbreastcancerpatients
AT steingarys identificationofmolecularlyuniquetumorassociatedmesenchymalstromalcellsinbreastcancerpatients
AT steinjanetl identificationofmolecularlyuniquetumorassociatedmesenchymalstromalcellsinbreastcancerpatients